Clarus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CRXTQ and buy or sell other stocks, ETFs, and their options commission-free!About CRXTQ
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Los Angeles, CA.
CEORobert E. Dudley, PhD
CEORobert E. Dudley, PhD
Employees—
Employees—
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2004
Founded2004
Employees—
Employees—
CRXTQ Key Statistics
Market cap72.80K
Market cap72.80K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume12.65K
Average volume12.65K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.94
52 Week high$3.94
52 Week low$0.001
52 Week low$0.001
Stock Snapshot
With a market cap of 72.8K, Clarus Therapeutics(CRXTQ) trades at $0.00.
Clarus Therapeutics(CRXTQ) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.
Clarus Therapeutics(CRXTQ) shares are trading with a volume of 0, against a daily average of 12.65K.
During the past year, Clarus Therapeutics(CRXTQ) stock moved between $0.00 at its lowest and $3.94 at its peak.
During the past year, Clarus Therapeutics(CRXTQ) stock moved between $0.00 at its lowest and $3.94 at its peak.
People also own
Based on the portfolios of people who own CRXTQ. This list is generated using Robinhood data, and it’s not a recommendation.